Januvia and Breast lump - a phase IV clinical study of FDA data

Summary:

Breast lump is reported as a side effect among people who take Januvia (sitagliptin phosphate), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Synthroid, and have High blood pressure.

The phase IV clinical study analyzes which people have Breast lump when taking Januvia. It is created by eHealthMe based on reports of 71,642 people who have side effects when taking Januvia from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Breast lump?

Breast lump (localized swelling that feels different from the surrounding breast tissue) is found to be associated with 778 drugs and 925 conditions by eHealthMe. Check the latest studies of Breast lump.

On Jul, 23, 2026

71,642 people reported to have side effects when taking Januvia.
Among them, 25 people (0.03%) have Breast lump.

Among these 25 people:

How long have people been on Januvia when they have Breast lump? *

What is the gender of people who have Breast lump when taking Januvia? *

female: 68 %
male: 32 %

What is the age of people who have Breast lump when taking Januvia? *

What are other drugs people take besides Januvia? *

What are other side effects people have besides Breast lump? *

Diarrhea: 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Skin Disorder (skin disease): 5 people, 20.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
High Blood Pressure: 5 people, 20.00%
Weakness: 4 people, 16.00%
Depression: 4 people, 16.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 16.00%
Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 16.00%
Back Pain: 4 people, 16.00%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 24.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 12.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 12.00%
High Blood Cholesterol: 3 people, 12.00%
Oedema Peripheral (superficial swelling): 2 people, 8.00%
Stress And Anxiety: 2 people, 8.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 8.00%
Pain: 1 person, 4.00%
Neuralgia (pain in one or more nerves): 1 person, 4.00%
Metastases To Bone (cancer spreads to bone): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and have Breast lump?

- Check whether Breast lump is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Januvia:

Januvia (72,818 reports)

Breast lump treatments and more:

Breast lump (9,236 reports)

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast lump:

Breast lump (778 drugs)

Browse all the conditions that are associated with Breast lump:

Breast lump (925 conditions)

Related publications that referenced our studies

Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate (the active ingredients of Januvia) and Januvia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.